| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.7 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |